Nibec Co Ltd
KOSDAQ:138610
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
13 070
52 300
|
| Price Target |
|
We'll email you a reminder when the closing price reaches KRW.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
Net Margin
Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.
Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.
Peer Comparison
| Country | Company | Market Cap |
Net Margin |
||
|---|---|---|---|---|---|
| KR |
N
|
Nibec Co Ltd
KOSDAQ:138610
|
386.7B KRW |
Loading...
|
|
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD |
Loading...
|
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
387B USD |
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
184.5B USD |
Loading...
|
|
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
174.7B USD |
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
121.5B USD |
Loading...
|
|
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR |
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
79.2B USD |
Loading...
|
|
| AU |
|
CSL Ltd
ASX:CSL
|
86.9B AUD |
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
44B EUR |
Loading...
|
|
| US |
S
|
Seagen Inc
F:SGT
|
39.3B EUR |
Loading...
|
Market Distribution
| Min | -168 471.3% |
| 30th Percentile | -2.9% |
| Median | 1.9% |
| 70th Percentile | 5.8% |
| Max | 21 012.5% |
Other Profitability Ratios
Nibec Co Ltd
Glance View
NIBEC Co., Ltd. engages in the development, manufacture, and commercialization of medical products and supplies. The company is headquartered in Jincheon, Chungcheongbuk-Do and currently employs 72 full-time employees. The company went IPO on 2011-07-13. The firm provides two main categories of products: dental health products and regeneration biomaterials. The dental health products consist of tooth whitening products under the brand name Blanc Tis; remedies for sensitive teeth under the brand name SensBlok, and dental conditioners under the brand name Clinplant. The regeneration biomaterials include bone graft materials under the brand name OCS-B, OCS-H and OCS-Collagen, as well as bone regenerative powders, bone morphogenetic materials, peptide bone powders and injectable gels. The company also provides cosmetics under the brand name Skin Aropa. The firm distributes its products within domestic market and to overseas markets.
See Also
Net Margin is calculated by dividing the Net Income by the Revenue.
The current Net Margin for Nibec Co Ltd is -7.3%, which is above its 3-year median of -35%.
Over the last 3 years, Nibec Co Ltd’s Net Margin has decreased from -4.1% to -7.3%. During this period, it reached a low of -62.5% on Sep 30, 2023 and a high of -3.4% on Sep 30, 2022.